Klingenstein Fields & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.2M Sell
221,534
-4,146
-2% -$966K 2.13% 17
2025
Q4
$46.7M Sell
225,680
-1,376
-0.6% -$272K 1.75% 18
2025
Q3
$42.1M Sell
227,056
-2,501
-1% -$428K 1.59% 20
2025
Q2
$35.1M Sell
229,557
-11,951
-5% -$1.84M 1.39% 23
2025
Q1
$40.1M Sell
241,508
-692
-0.3% -$108K 1.7% 19
2024
Q4
$35M Sell
242,200
-2,772
-1% -$430K 1.41% 24
2024
Q3
$39.7M Sell
244,972
-2,038
-0.8% -$325K 1.58% 21
2024
Q2
$36.1M Sell
247,010
-2,548
-1% -$379K 1.5% 22
2024
Q1
$39.5M Sell
249,558
-6,694
-3% -$1.07M 1.64% 17
2023
Q4
$40.2M Sell
256,252
-12,727
-5% -$1.95M 1.79% 14
2023
Q3
$41.9M Buy
268,979
+1,120
+0.4% +$185K 2.05% 13
2023
Q2
$44.3M Sell
267,859
-3,522
-1% -$568K 2.05% 12
2023
Q1
$42.1M Sell
271,381
-4,617
-2% -$746K 2.11% 11
2022
Q4
$48.8M Sell
275,998
-5,095
-2% -$880K 2.53% 8
2022
Q3
$45.9M Buy
281,093
+2,253
+0.8% +$381K 2.53% 10
2022
Q2
$49.5M Sell
278,840
-1,373
-0.5% -$245K 2.57% 9
2022
Q1
$49.7M Sell
280,213
-3,126
-1% -$532K 2.13% 12
2021
Q4
$48.5M Sell
283,339
-12,461
-4% -$2.04M 1.95% 14
2021
Q3
$47.8M Sell
295,800
-7,324
-2% -$1.25M 2.04% 14
2021
Q2
$49.9M Sell
303,124
-2,975
-1% -$493K 2.07% 12
2021
Q1
$50.3M Sell
306,099
-128,698
-30% -$20.8M 2.27% 11
2020
Q4
$68.4M Sell
434,797
-165,687
-28% -$24.5M 3.1% 5
2020
Q3
$89.4M Sell
600,484
-7,009
-1% -$1.04M 4.46% 2
2020
Q2
$85.4M Sell
607,493
-1,846
-0.3% -$269K 4.67% 1
2020
Q1
$79.9M Sell
609,339
-4,423
-0.7% -$628K 5.21% 1
2019
Q4
$89.5M Buy
613,762
+75,668
+14% +$10.3M 4.5% 2
2019
Q3
$69.6M Buy
538,094
+1,928
+0.4% +$254K 3.68% 3
2019
Q2
$74.7M Sell
536,166
-6,260
-1% -$867K 3.88% 3
2019
Q1
$75.8M Sell
542,426
-250,204
-32% -$33.5M 4.07% 2
2018
Q4
$102M Sell
792,630
-11,231
-1% -$1.57M 4.34% 4
2018
Q3
$111M Sell
803,861
-67,754
-8% -$9M 3.98% 4
2018
Q2
$106M Sell
871,615
-3,707
-0.4% -$462K 4.03% 4
2018
Q1
$112M Sell
875,322
-16,351
-2% -$2.21M 4.29% 4
2017
Q4
$125M Sell
891,673
-13,194
-1% -$1.84M 4.58% 4
2017
Q3
$118M Sell
904,867
-28,179
-3% -$3.74M 4.53% 4
2017
Q2
$123M Sell
933,046
-3,756
-0.4% -$479K 4.84% 4
2017
Q1
$117M Buy
936,802
+177,350
+23% +$21.2M 4.74% 4
2016
Q4
$87.5M Buy
759,452
+4,686
+0.6% +$541K 3.82% 4
2016
Q3
$89.2M Buy
754,766
+3,009
+0.4% +$365K 4.1% 4
2016
Q2
$91.2M Buy
751,757
+13,726
+2% +$1.56M 4.26% 4
2016
Q1
$79.9M Sell
738,031
-12,127
-2% -$1.26M 3.99% 4
2015
Q4
$77.1M Sell
750,158
-15,555
-2% -$1.56M 3.82% 4
2015
Q3
$71.5M Sell
765,713
-14,620
-2% -$1.41M 3.54% 4
2015
Q2
$76.1M Sell
780,333
-22,166
-3% -$2.22M 3.4% 4
2015
Q1
$80.7M Sell
802,499
-1,408
-0.2% -$143K 3.57% 4
2014
Q4
$84.1M Sell
803,907
-10,634
-1% -$1.12M 3.75% 4
2014
Q3
$86.8M Sell
814,541
-4,640
-0.6% -$481K 3.79% 5
2014
Q2
$85.7M Sell
819,181
-3,938
-0.5% -$398K 3.64% 5
2014
Q1
$80.9M Sell
823,119
-210,200
-20% -$19.5M 3.63% 5
2013
Q4
$94.6M Sell
1,033,319
-7,044
-0.7% -$649K 3.39% 5
2013
Q3
$90.2M Sell
1,040,363
-41,985
-4% -$3.77M 3.53% 5
2013
Q2
$92.9M Buy
+1,082,348
New +$91.8M 3.33% 5

Other funds holding JNJ

Klingenstein Fields & Co's JNJ Position: Q1 2026 in Review

Klingenstein Fields & Co reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $966K and leaving 221,534 shares worth $54.2M. The position accounts for 2.13% of the portfolio, ranked #17.

Klingenstein Fields & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $125M in Q4 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Klingenstein Fields & Co held 221,534 shares of Johnson & Johnson worth $54.2M as of Q1 2026.
  • Klingenstein Fields & Co sold 4,146 Johnson & Johnson shares in Q1 2026, an estimated $966K.
  • Johnson & Johnson made up 2.13% of Klingenstein Fields & Co's portfolio in Q1 2026, its #17 holding.
  • Klingenstein Fields & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Klingenstein Fields & Co's Johnson & Johnson position peaked at $125M in Q4 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.